A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Scientists have discovered two giant mystery structures lurking under Africa
Tired of Elon Musk? Here are the Twitter alternatives you should know about
Bitcoin price dramatically crashes amid market worries
Trilliant Health’s 2023 SimilarityIndex™ | Hospitals Reveals Wide Variation in Commercial Reimbursement Despite Similar Quality and Patient Acuity
These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Activision, Dollar General, Smart Global, and More
AI breakthrough could help us build solar panels out of ‘miracle material’, scientists say
Ukrainian schoolboy to buy home for his mother after selling Minecraft server
Movius Appoints Lisa Davis to Board of Directors